Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 22, 2025 06:00 ET | Source: AskBio Inc. (AskBio)

First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson’s Disease

Research Triangle Park, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- AB-1005, a glial cell line-derived neurotrophic factor (GDNF) investigational gene therapy, is being evaluated for the treatment...
September 17, 2025 08:00 ET | Source: AskBio Inc. (AskBio)

AskBio Announces Completion of Enrollment in Phase 1 Clinical Trial of AB-1005 Gene Therapy for Multiple System Atrophy-Parkinsonian Type (MSA-P)

Research Triangle Park, N.C., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Final participant randomized to complete enrollment in Phase 1 clinical trial assessing safety of investigational gene therapy...
September 16, 2025 17:17 ET | Source: D S Simon

Expert with Bayer Discusses the U.S. Launch of Aspirina Families with YourUpdateTV

NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Bayer’s Aspirina, the #1 pain relief option in Mexico* and a leading brand across Latin America, is now available in the United States. Recently, Dr....
August 21, 2025 08:02 ET | Source: AgTech Breakthrough

Bayer's E.L.Y. Wins “AI-based AgTech Solution of the Year” In 2025 AgTech Breakthrough Awards Program

LOS ANGELES, Aug. 21, 2025 (GLOBE NEWSWIRE) -- AgTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global agricultural...
June 27, 2025 15:51 ET | Source: Cohen Milstein Sellers & Toll PLLC

Court Approves $38M Cash Settlement Against Bayer AG in Hard-Fought Securities Class Action

Following the Bayer-Monsanto merger, litigation has resulted in a valuable settlement that, pending final approval, affirms the rights of ADR investors to
May 27, 2025 08:51 ET | Source: AskBio Inc. (AskBio)

AskBio Announces Publication of Complete Results of Phase 1b Trial of AB-1005 Gene Therapy in Participants with Parkinson’s Disease in Movement Disorders

Research Triangle Park, N.C., May 27, 2025 (GLOBE NEWSWIRE) -- AB-1005 was well tolerated with no attributed serious adverse events in participants with mild or moderate Parkinson’s disease (PD)...
May 19, 2025 08:07 ET | Source: AskBio Inc. (AskBio)

AskBio Presents Complete Results of Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure at European Society of Cardiology Heart Failure Meeting

Research Triangle Park, N.C., May 19, 2025 (GLOBE NEWSWIRE) --First-in-human trial of AB-1002 designed to evaluate safety and preliminary efficacy in participants with New York Heart Association...
May 08, 2025 08:00 ET | Source: Asklepios BioPharmaceutical, Inc. (AskBio)

AskBio Announces 15 Presentations at American Society of Gene and Cell Therapy 28th Annual Meeting

Research Triangle Park, N.C., May 08, 2025 (GLOBE NEWSWIRE) --Three oral and 12 poster presentations demonstrate breadth and progress of AskBio’s gene therapy research and development...
April 08, 2025 09:23 ET | Source: Asklepios BioPharmaceutical, Inc. (AskBio)

AskBio Elects Dr. Laura Sepp-Lorenzino Independent Member of Board of Directors

Research Triangle Park, N.C., April 08, 2025 (GLOBE NEWSWIRE) -- Dr. Sepp-Lorenzino brings to AskBio over 30 years of executive, academic, and Board experienceOther Board positions include Taysha...
March 31, 2025 12:30 ET | Source: Custom Market Insights

[Latest] Global Home Gardening Market Size/Share Worth USD 26.47 Billion by 2034 at a 5.92% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, March 31, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Home Gardening Market Size, Trends and Insights By Gardener Type (Professional...